Bal Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 73.94 | 96.81 | 81.74 |
| Operating Expense | 66.06 | 84.26 | 73.96 |
| Net Profit | 1.75 | 6.22 | 1.26 |
| Net Profit Margin | 2.37 | 6.42 | 1.54 |
| Earning Per Share | 1.11 | 4.16 | 0.80 |
| EBIDTA | 8.09 | 10.67 | 8.03 |
| Effective Tax Rate | 6.97 | -11.39 | 8.48 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 73.94 |
| Operating Expense | 66.06 |
| Net Profit | 1.75 |
| Net Profit Margin | 2.37 |
| Earning Per Share | 1.11 |
| EBIDTA | 8.09 |
| Effective Tax Rate | 6.97 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 338.54 | 303.10 | 280.37 |
| Operating Expenses Annual | 306.10 | 276.80 | 257.16 |
| Operating Profit Annual | 35.79 | 28.49 | 29.69 |
| Interest Annual | 15.24 | 12.46 | 10.40 |
| Depreciation | 4.53 | 5.52 | 5.77 |
| Net Profit Annual | 10.27 | 6.13 | 8.58 |
| Tax Annual | 1.83 | 2.42 | 3.48 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 338.54 |
| Operating Expenses Annual | 306.10 |
| Operating Profit Annual | 35.79 |
| Interest Annual | 15.24 |
| Depreciation | 4.53 |
| Net Profit Annual | 10.27 |
| Tax Annual | 1.83 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.23 | 0.81 | 0.89 |
| Cash Flow from Operations | 28.95 | 5.38 | 30.57 |
| Cash Flow from Investing | -18.43 | -22.08 | -13.43 |
| Cash Flow from Financing | -7.71 | 17.12 | -17.22 |
| Cash Flow at the End | 4.04 | 1.23 | 0.81 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1.23 |
| Cash Flow from Operations | 28.95 |
| Cash Flow from Investing | -18.43 |
| Cash Flow from Financing | -7.71 |
| Cash Flow at the End | 4.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 10.63 | 9.44 | 10.22 |
| PBIT Margin (%) | 8.13 | 6.97 | 7.64 |
| PBT Margin (%) | 7.60 | 6.42 | 6.92 |
| Net PROFIT Margin (%) | 3.03 | 2.02 | 3.06 |
| Return On Networth / Equity (%) | 10.19 | 6.69 | 9.36 |
| Return On Networth /Employed (%) | 11.63 | 10.08 | 11.20 |
| Return On Assets (%) | 4.34 | 2.91 | 4.47 |
| Total Debt / Equity (X) | 1.28 | 1.22 | 1.21 |
| Asset Turnover Ratio (%) | 1.43 | 1.44 | 1.46 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 10.63 |
| PBIT Margin (%) | 8.13 |
| PBT Margin (%) | 7.60 |
| Net PROFIT Margin (%) | 3.03 |
| Return On Networth / Equity (%) | 10.19 |
| Return On Networth /Employed (%) | 11.63 |
| Return On Assets (%) | 4.34 |
| Total Debt / Equity (X) | 1.28 |
| Asset Turnover Ratio (%) | 1.43 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 64.56 | 63.07 | 52.90 |
| Total Current Assets Annual | 281.14 | 269.95 | 218.20 |
| Non Current Assets Annual | 80.16 | 77.75 | 71.56 |
| Total Shareholders Funds Annual | 105.58 | 96.03 | 87.32 |
| Total Assets Annual | 361.30 | 347.70 | 289.76 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 64.56 |
| Total Current Assets Annual | 281.14 |
| Non Current Assets Annual | 80.16 |
| Total Shareholders Funds Annual | 105.58 |
| Total Assets Annual | 361.30 |
EPS (INR)
Expected
0.16
Reported
0.16
Surprise
0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 7.80%
Sep 2023
EPS beaten by -3.57%
